Troy Wichterman serves as the Chief Financial Officer at BioLife Solutions Inc., a leading provider of bioproduction tools and services for the cell and gene therapy industry. With a robust background in finance and strategic planning, Wichterman has been instrumental in guiding BioLife Solutions through significant growth and development. He joined the company in 2018 and has since played a pivotal role in its financial strategy, including overseeing mergers and acquisitions that have expanded BioLife's market reach and capabilities. Prior to his tenure at BioLife Solutions, Wichterman held several key financial positions that honed his expertise in the life sciences sector. He previously served as the CFO at OncoGenex Pharmaceuticals, where he was responsible for managing the company's financial operations during a critical phase of clinical development. Earlier in his career, he worked at Oncothyreon Inc., also in a senior financial capacity, where he helped navigate the company through complex financial landscapes. Wichterman's strategic foresight and financial acumen have been crucial in driving BioLife Solutions' successful trajectory, ensuring the company's continued innovation and market leadership in the bioproduction space. In his role at BioLife Solutions, Wichterman is responsible for all aspects of the company's financial management, including budgeting, forecasting, and investor relations. His leadership has been vital in securing funding and partnerships that support BioLife's mission to advance the field of cell and gene therapies. Under his guidance, the company has achieved notable milestones, such as the successful integration of acquired businesses and the expansion of its product portfolio. Wichterman's dedication to excellence and strategic vision continue to propel BioLife Solutions forward, cementing its position as a key player in the biopharmaceutical industry.